Cardio Diagnostics Holdings, Inc's Actionable Clinical IntelligenceTM (ACI) Platform Offers New Epigenetic and Genetic Insights to Inform Coronary Heart Disease Management
The platform is designed to expand the information available to clinicians prescribing the Epi+Gen CHD and PrecisionCHD laboratory developed tests (LDTs)
Tim Dogan Meesha Dogan Cardio Diagnostics Holdings Inc Diagnostics Holdings Actionable Clinical Intelligence Chief Technology Officer
Source: dicardiology.com